Skip to main navigation
Our Science
Nucleos(t)ides
Pipeline & Programs
Hepatitis C
Bemnifosbuvir / Ruzasvir
About Hepatitis C
About Atea
About Us
Leadership
Careers
Contact
Investors
Overview
News & Events
News Releases
Events & Presentations
Publications
Financials
Annual Meeting
SEC Filings
Annual Reports
Quarterly Reports
Stock Info
Stock Quote & Chart
Historical Price Look up
Analyst Coverage
Corporate Governance
Documents & Charters
Management Team
Board of Directors
Committee Composition
Shareholder Resources
Investor FAQs
Email Alerts
Contact IR
RSS Feeds
Investor Relations
144
Breadcrumb
Investors
144
> Back to SEC
Go Back
SEC Filing Details
Form
144
Filing Date
November 16, 2026
Document Date
November 16, 2026
Form Description
Filed by "insiders" prior intended sale of restricted stock.
Filing Group
Other
Company
Atea Pharmaceuticals, Inc.
Issuer
Atea Pharmaceuticals, Inc.
Filing Formats
View HTML
Download PDF
Download DOC
Investor FAQs
RSS Feeds
Email Alerts
Contact IR